stockrowDENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) Return on assets
DENTSPLY SIRONA Inc.'s return on assets over the twelve months to 30 September 2026 was −2.23%, up 8.5 percentage points from fiscal 2025 (−10.7%). Over the past ten years it has ranged from −14.1% (fiscal 2017) to 5.55% (fiscal 2015); the current reading is higher than 36% of that period. That is below the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −10.7% | 3.17 |
| FY2024 | −13.9% | (12.11) |
| FY2023 | −1.76% | 9.49 |
| FY2022 | −11.3% | (15.67) |
| FY2021 | 4.42% | 5.23 |
| FY2020 | −0.81% | (3.77) |
| FY2019 | 2.96% | 13.57 |
| FY2018 | −10.6% | 3.53 |
| FY2017 | −14.1% | (19.53) |
| FY2016 | 5.39% | (0.16) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| LMAT LeMaitre Vascular, Inc. compare | 10.1% |
| STVN Stevanato Group S.p.A. compare | 5.50% |
| ATRC AtriCure, Inc. compare | 2.20% |
| WRBY Warby Parker Inc. compare | 1.00% |
| STAA STAAR Surgical Company compare | 0.11% |
| XRAY DENTSPLY SIRONA Inc. | −2.23% |
| AZTA Azenta, Inc. compare | −6.31% |
| KMTS Kestra Medical Technologies, Ltd. compare | −48.9% |
| PLSE Pulse Biosciences, Inc compare | −54.0% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement